Datavault AI Grants Scilex Exclusive License for AI-Driven Biotech Exchange Platform

Datavault AI Inc. has granted Scilex Holding Company an exclusive worldwide license to deploy its proprietary AI-driven technology within the biotech and biopharma sectors. The agreement enables Scilex to build and operate a Biotech Exchange platform to tokenize, trade, and monetize biotech assets such as genomic data, diagnostics, and drug information. This licensing arrangement represents a significant step toward creating new market infrastructure for the biotechnology industry.

The technology is expected to expand into a Pharmaceutical Exchange platform addressing an estimated $2 trillion market opportunity. This expansion would provide companies with pathways to access non-dilutive funding, potentially revolutionizing how biotech and pharmaceutical companies finance their operations and research. The financial terms of the agreement include a $10 million upfront payment in four installments and up to $2.55 billion in potential milestone payments, reflecting the substantial value both companies see in this technology application.

Datavault AI's technology is supported by the company's broad patent portfolio and proven high-performance computing expertise. The company's cloud-based platform provides comprehensive solutions with a collaborative focus through its Acoustic Science and Data Science Divisions. The Data Science Division specifically leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation and secure monetization across multiple industries.

The Information Data Exchange enables Digital Twins and licensing of name, image, and likeness by securely attaching physical real-world objects to immutable metadata objects. This technology fosters responsible AI with integrity while offering completely customizable AI and Machine Learning automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. More information about Datavault AI's technology platform can be found at https://www.datavaultsite.com.

This licensing agreement positions Scilex to leverage Datavault AI's established infrastructure for creating secure, tokenized marketplaces. The technology suite's ability to serve multiple industries including sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, and energy demonstrates its versatility and scalability. The latest updates relating to Datavault AI are available through the company's newsroom at https://ibn.fm/DVLT.